Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Natural Biocon (India)'s Revenue for the
three
months ended in Jun. 2026 was ₹0.00 Mil. Natural Biocon (India)'s average Accounts Receivable for the
three
months ended in Jun. 2026 was ₹51.43 Mil.
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Natural Biocon (India) Receivables Turnover Related Terms
Natural Biocon (India) Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Natural Biocon (India)'s Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:543207 vs LIN, SHW, ECL: Receivables Turnover Comparison
For the Specialty Chemicals subindustry, Natural Biocon (India)'s Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Natural Biocon (India) Receivables Turnover vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Natural Biocon (India)'s Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Natural Biocon (India)'s Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Natural Biocon (India) (BOM:543207) has a Receivables Turnover of 0.00 as of Jun. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Natural Biocon (India) and its competitors. According to the industry distribution chart, Natural Biocon (India) ranks #1577 out of 1581 companies in the Chemicals industry, placing it in the top 99.7%.
Is Natural Biocon (India)'s Receivables Turnover too high?
Natural Biocon (India)'s current Receivables Turnover is 0.00. Based on the distribution chart, Natural Biocon (India) ranks #1577 out of 1581 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, Natural Biocon (India) has a GF Score™ of 58/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Natural Biocon (India)'s Receivables Turnover compare to LIN and SHW?
According to the Chemicals industry distribution chart, Natural Biocon (India) ranks #1577 out of 1581 companies for Receivables Turnover. This places Natural Biocon (India) in the lower half of its industry. The industry median Receivables Turnover is 5.76. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Chemicals company?
The median Receivables Turnover among Chemicals companies is 5.76, based on 1,581 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Natural Biocon (India) and its competitors. For the Chemicals industry, the median Receivables Turnover is 5.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Natural Biocon (India)'s current Receivables Turnover is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Natural Biocon (India) stock overvalued right now?
Based on GuruFocus' analysis, Natural Biocon (India) (BOM:543207) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹0.93, compared to a current price of ₹3.52 — trading 278.5% above its estimated fair value. The current Receivables Turnover is 0.00. Natural Biocon (India)'s overall GF Score™ is 58/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Natural Biocon (India) (BOM:543207), the current Receivables Turnover is 0.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Natural Biocon (India) (BOM:543207) Overvalued in 2026?
Based on GuruFocus' analysis, Natural Biocon (India) stock appears to be overvalued.
The current stock price of ₹3.52 is trading 278.5% above its estimated GF Value™ of ₹0.93.
GuruFocus considers Natural Biocon (India) to be Significantly Overvalued.
Key valuation signals for BOM:543207:
Receivables Turnover: 0.00
GF Value™: ₹0.93 vs. price of ₹3.52 (278.5% above fair value)
No single metric tells the full story. See the BOM:543207 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Natural Biocon (India) Ltd is engaged in the business of chemicals, natural extracts, and agricultural products. The company manufactures natural food colors. Its revenue stream is retail trading of commodities, which are generated through the sale of chemicals in Ahmedabad and Mumbai. The company generates revenue and operates within India.
58GF Score
Get the complete analysis for BOM:543207
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:543207 has been successfully added to your 
